期刊文献+

丙型肝炎病毒自发清除者的血清代谢组学研究 被引量:4

A metabonomics study of patients with spontaneous clearance of hepatitis C virus
原文传递
导出
摘要 目的探索HCV自发清除者、慢性丙型肝炎(丙肝)及健康人血清代谢组学的差异。方法纳入HCV自发清除者、慢性丙肝患者和健康对照各30例,采用快速液相色谱一串联质谱联用(LC—MS/MS)技术,应用主成分分析(PCA)、正交偏最小二乘法一判别分析(OPLS-DA)进行模式识别,然后通过变量重要性因子(VIP)、非参数检验,结合数据库检索筛选鉴定有差异的代谢物。结果25个变量被确认为存在显著差异的代谢物,其中7个变量被鉴定为花生四烯酸、棕榈油酸、葵酰基肉碱、溶血磷脂酰胆碱(20:5,16:0)、溶血磷脂酰乙醇胺(16:0,18:0),涉及脂肪酸、磷脂等代谢。其中花生四烯酸以及未鉴定出明确结构的m/z179.0719、m/z382.1360、m/z548.3475、m/z680.4281、m/z303.2323等物质与自发清除组的相关性较好,受试者工作特征曲线下面积为0.887-0.977,具有较好的特异度和敏感度。结论HCV自发清除者、慢性丙肝感染者、健康人在血清代谢水平上存在明显差异,这些差异的意义有待进一步探索。 Objective To explore the difference of serum metabonomics among patients with spontaneous clearance of hepatitis C virus (HCV), patients with chronic hepatitis C (CHC) and healthy controls. Methods Thirty patients with spontaneous clearance of HCV, 30 patients with CHC and 30 healthy controls were enrolled in this study. Rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) and performed pattern recognition by principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) in each group was applied. Then several metabolites which were different among the 3 groups through variable importance in projection (VIP) value, non-parametric test and screening in databases was identified. Results Twenty-five variables that were significantly different among the 3 groups were considered as potential biomarkers, among which 7 variables were identified as arachidonic acid, palmitoleic acid, dodecanoylcarnitine, lysophosphatidylcholine ( LysoPC [20:5 (5Z, 8Z, llZ, 14Z, 17Z)]}, LysoPC (16:0), Lysophosphatidylethanolamine [LysoPE (18:0)], LysoPE (16:0), all related to the metabolism of fatty acid and phospholipids. Especially, there was a good correlation between arachidonic acid as well as some other variables whose structures were not identified clearly, such as m/z 179. 0719, m/z382. 1360, m/z 548. 3475, m/z 680. 4281 and m/z 303. 2323, and patients with spontaneous clearance of HCV, with an area under the curve (AUC) from 0. 887 to 0. 977 and good specificity and sensitivity. Conclusion A marked difference of serum metabolic profiles exists among patients with spontaneous clearance of HCV, patients with CHC and healthy controls, and its clinical significance requires further study.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2013年第2期101-106,共6页 Chinese Journal of Infectious Diseases
基金 国家自然科学基金资助项目(81172727,81072347) 国家科技重大专项“十二五”课胚“病毒性肝炎转归预警预测的研究”(2012ZX100002007) 中国科学院国家外国专家局创新团队国际合作伙伴计划
关键词 肝炎 丙型 慢性 肝炎病毒属 色谱法 高压液相 串联质谱法 最小二乘法分析 Hepatitis C, chronic Hepacivirus Chromatography, high pressure liquid Tandem mass spectrometry Least-squares analysis
  • 相关文献

参考文献18

  • 1Seeff LB. Natural history of chronic hepatitis C. Hepatology, 2002, 36:S35-46.
  • 2丙型肝炎防治指南[J].中华传染病杂志,2004,22(2):131-136. 被引量:224
  • 3World Health Organization. Hepatitis C [DB/OL]. 2002 [2012-07-31]. http://www, who. int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index, html.
  • 4Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature, 2009, 461: 399-401.
  • 5Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon- alpha and ribavirin therapy. Nat Genet, 2009, 41: 1100- 1104.
  • 6Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon- alpha and ribavirin therapy for chronic hepatitis C. Nat Genet, 2009, 41: 1105-1109.
  • 7Horning MG, Murakami S, Horning EC. Analyses of phospholipids, ceramides, and cerebrosides by gas chromatography and gas chromatography-mass spectrometry. Am J ClinNutr, 1971, 24: 1086-1096.
  • 8Nicholson JK, Lindon JC, Holmes E. ' Metabonomics:understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 1999, 29: i181-i189.
  • 9Nicholson JK, Wilson ID. Opinion: understanding "global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov, 2003, 2: 668-676.
  • 10Taylor J, King RD, Altmann T, et al. Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformaties, 2002, 18 Suppl 2: S241-248.

二级参考文献13

  • 1Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class lI eytokine receptor IL - 28R[ J]. Nat Immunol, 2003,4( 1 ) : 63 - 68.
  • 2Witte K, Gruetz G, Volk HD, et al. Despite IFN - lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines[ J ]. Genes Immun,2009, 10(8):702 -714.
  • 3O'Brien TR. Interferon- alfa, interferon- lambda and hepatitis C [ J]. Nat Genet,2009, 41 (10) : 1048 - 1050.
  • 4Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment- induced viral clearance[ J]. Nature, 2009,461 (7262) : 399 -401.
  • 5Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon - alpha and ribavirin therapy [ J ]. Nat Genet,2009, 41 (10) : 1100 - 1104.
  • 6Tanaka Y, Nishida N, Sugiyama M, et al. Genome - wide association of IL28B with response to pegylated interferon - alpha and ribavirin therapy for chronic hepatitis C [ J]. Nat Genet,2009, 41 (10) :1105 -1109.
  • 7Thomas DL, Martin MP, Ying Qi, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus [ J ]. Nature, 2009, 461 (7265) : 798 - 801.
  • 8Ghany MG, Strader DB, Seeff, LB, et al. Diagnosis, management, and treatment of hepatitis C : an update [ J ]. Hepatology, 2009, 49 (4): 1335 - 1374.
  • 9Sarasin- Filipowicz M, Oakeley EJ, Duong FHT, et al. Interferon signaling and treatment outcome in chronic hepatitis C [ J]. Proc Natl Acad Sci U S A, 2008,105 ( 19 ) : 7034 - 7039.
  • 10康来仪,孙永德,郝连杰,曹学义,潘启超.我国丙型和戊型肝炎人群流行病学调查及流行因素的研究[J].中华传染病杂志,1997,15(2):71-75. 被引量:99

共引文献235

同被引文献25

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部